HomeInsightsStock Comparison

Alacrity Securities Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Alacrity Securities Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 18, 2025

Key Highlights

  • The Latest Trading Price of Alacrity Securities Ltd is ₹ 75 as of 16 May 15:30.
  • The P/E Ratio of Alacrity Securities Ltd is 0 as of March 2020 .The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2020.
  • The Market Cap of Alacrity Securities Ltd is ₹ 0 crore as of March 2020 .The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 1.57 crore as of March 2020.
  • The revenue of Alacrity Securities Ltd for the Dec '24 is ₹ 160.37 crore as compare to the Sep '24 revenue of ₹ 238.41 crore. This represent the decline of -32.73% The revenue of Novelix Pharmaceuticals Ltd for the Dec '24 is ₹ 5.3 crore as compare to the Sep '24 revenue of ₹ 3.87 crore. This represent the growth of 36.95%.
  • The ebitda of Alacrity Securities Ltd for the Dec '24 is ₹ 10.79 crore as compare to the Sep '24 ebitda of ₹ 7.93 crore. This represent the growth of 36.07% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '24 is ₹ 0.13 crore as compare to the Sep '24 ebitda of ₹ 0.14 crore. This represent the decline of -7.14%.
  • The net profit of Alacrity Securities Ltd changed from ₹ 3.57 crore to ₹ 7 crore over 7 quarters. This represents a CAGR of 46.93% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ -0.17 crore to ₹ 0.15 crore over 7 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Alacrity Securities Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alacrity Securities Ltd

  • Alacrity Securities Limited was originally incorporated in Mumbai as a Private Limited Company under the name and style of 'Alacrity Securities Private Limited' on December 20, 1994 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
  • The Company became a Deemed Public Company w.e.f July 1, 1999 under the erstwhile provisions of Section 43-A (1A) of the Companies Act, 1956.
  • However, the Management decided to retain the status of the Company as Public Limited effective on 30th June, 2001 and the name of the Company was changed from 'Alacrity Securities Private Limited' to 'Alacrity Securities Limited'. The Company was originally incorporated by Ms. Nalini Prabhu & Mr. Anil Prabhu with the intention to carry on the business of an investment Company.
  • Later on, in year 1996, Mr.

About Novelix Pharmaceuticals Ltd

  • Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
  • Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
  • They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
  • Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

Alacrity Securities Ltd News Hub

News

Alacrity Securities to discuss results

Alacrity Securities will hold a meeting of the Board of Directors of the Company on 27 May...

Read more

16 May 2025 15:57

News

Alacrity Securities to hold board meeting

Alacrity Securities will hold a meeting of the Board of Directors of the Company on 24 Mar...

Read more

20 Mar 2025 10:03

News

Alacrity Securities to hold board meeting

Alacrity Securities will hold a meeting of the Board of Directors of the Company on 21 Mar...

Read more

19 Mar 2025 09:41

News

Alacrity Securities to hold board meeting

Alacrity Securities will hold a meeting of the Board of Directors of the Company on 12 Feb...

Read more

07 Feb 2025 10:48

News

Alacrity Securities announces board meeting date

Alacrity Securities will hold a meeting of the Board of Directors of the Company on 12 Nov...

Read more

29 Oct 2024 15:27

News

Alacrity Securities AGM scheduled

Alacrity Securities announced that the Annual General Meeting (AGM) of the company will be...

Read more

18 Sep 2024 10:13

Novelix Pharmaceuticals Ltd News Hub

News

Novelix Pharmaceuticals to convene EGM

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

15 Apr 2025 10:33

News

Trimurthi to table results

Trimurthi will hold a meeting of the Board of Directors of the Company on 12 February 2025...

Read more

08 Feb 2025 10:47

News

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

09 Nov 2024 17:04

News

Trimurthi revises board meeting date

Trimurthi has revised the meeting of the Board of Directors which was scheduled to be held...

Read more

14 Oct 2024 10:29

News

Trimurthi to hold board meeting

Trimurthi will hold a meeting of the Board of Directors of the Company on 14 October 2024....

Read more

08 Oct 2024 10:44

News

Trimurthi schedules AGM

Trimurthi announced that the Annual General Meeting (AGM) of the company will be held on 2...

Read more

14 Sep 2024 17:30

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Alacrity Securities Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novelix Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alacrity Securities Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alacrity Securities Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Alacrity Securities Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Alacrity Securities Ltd is 349 Cr while Market cap of Novelix Pharmaceuticals Ltd is 69 Cr

What are the key factors driving the stock performance of Alacrity Securities Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Alacrity Securities Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alacrity Securities Ltd and Novelix Pharmaceuticals Ltd?

As of May 18, 2025, the Alacrity Securities Ltd stock price is INR ₹75.0. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹27.94.

How do dividend payouts of Alacrity Securities Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Alacrity Securities Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions